Bio-Eye® Hydroxyapatite (HA) Orbital Implant from Bio-Eye Orbital Implants

Description

The Bio-eye hydroxyapatite (HA) orbital implant was conceived by Arthur C. Perry, M.D., in the early 1980s, after a comprehensive review of the literature on orbital implants, which included the earliest manuscripts dating back to 1885 (Mules 1885). This review, along with an ongoing dissatisfaction with the performance of contemporary implants, allowed Perry to identify the performance characteristics of an ideal orbital implant and, perhaps more importantly, led to the identification of the key physical design variables that accounted for the relative success or failure of a given orbital implant.

The natural hydroxyapatite orbital implant has the longest successful track record of any known implant material that can successfully accommodate a motility/support peg, which directly connects the artificial eye to the implant. The complete interconnected porosity filled with fibrovascular ingrowth makes this possible. The motility/support peg supports the weight of the prosthesis while simultaneously ensuring transfer of any socket movement directly to the prosthesis.

The Coated Bio-eye Hydroxyapatite Orbital Implant became available in November 2003. This is the most scientifically engineered and medically designed implant in the world.

  • Detailed Specifications
  • ItemBio-Eye® Hydroxyapatite (HA) Orbital Implant
  • CompanyBio-Eye Orbital Implants
  • PriceInquire
  • Features
    • Maintain Natural Lid Shape
      The implant must provide a means, such as the ability to receive a motility/support peg, to support the weight of the artificial eye to prevent damage to the delicate muscles of the lower lids over time
    • Light Weight
      The implant must be light in weight.
    • Porosity
      The implant must allow vascular orbital tissues to invade its structure to: a) lock it into place and prevent migration, b) allow it to fight infections from within the implant via the vascular bed infiltrating the implant, and c) support "healing from within" of any defect in the conjunctival-Tenon's closure
    • True Integration
      The implant must be directly integrated (e.g., via a peg) with the artificial eye to allow direct transfer of all available movement from the rectus muscles to the artificial eye
    • Natural Biocompatibility
      The implant must be a natural material and readily accepted by the tissues of the orbit to prevent "synthetic implant syndrome" i.e., pseudocapsule formation around the implant. This pseudocapsule is the body's way of walling off a foreign material.
  • ApprovalUS FDA
  • Product NumberInquire
  • StatusCoated Bio-eye Hydroxyapatite Orbital Implant became available in November 2003
  • Size (mm)available in a broad assortment of sizes to meet any patient need